Immunological rejection episodes · adult patients after liver transplantation.
It is very uncertain whether enteral immunonutrion with Supportan changes immunological rejection episodes compared with enteral nutrition (EN) with Fresubin (very low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review
Intensive care unit length of stay after liver transplantation [days] (ITT) · adult patients after liver transplantation.
1 finding from 1 review
Acute rejection · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes acute rejection episodes compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
All‐cause mortality · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes mortality compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review
Days on ventilator · adult patients after liver transplantation.
1 finding from 1 review
All‐cause mortality · adult patients after liver transplantation.
It is very uncertain whether postoperative enteral nutrition (Osmolite) via nasojejunal tube changes mortality compared with postoperative parenteral nutrition (PN) (very low certainty).
1 finding from 1 review
Putative side effects of treatment (e.g. vomiting and diarrhoea) · adult patients after liver transplantation.
It is very uncertain whether postoperative enteral nutrition (Osmolite) via nasojejunal tube changes side effects (vomiting, diarrhoea) compared with postoperative parenteral nutrition (PN) (very low certainty).
1 finding from 1 review
Infection (overall) · adult patients after liver transplantation.
It is very uncertain whether postoperative enteral nutrition (Osmolite) via nasojejunal tube changes infection (overall) compared with postoperative parenteral nutrition (PN) (very low certainty).
1 finding from 1 review
All‐cause mortality during hospital stay · adult patients after liver transplantation.
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes death (during length of initial hospital stay; ITT) compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Infection (ITT) ‐ mycotic infection · adult patients after liver transplantation.
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes infection (ITT) ‐ mycotic infection compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Infection (ITT) ‐ infection (overall) · adult patients after liver transplantation.
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes infection (ITT) ‐ infection (overall) compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Acute rejection · adult patients after liver transplantation.
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes acute rejection (ITT) compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review
Intensive care unit length of stay after liver transplantation [days] (ITT) · adult patients after liver transplantation.
1 finding from 1 review
Days on ventilator · adult patients after liver transplantation.
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
2 findings from 1 review
Days on ventilator · adult patients after liver transplantation.
1 finding from 1 review
Mortality [within first 10 weeks after liver transplantation] · adult patients after liver transplantation.
Standard parenteral nutrition may leads to lower mortality [within first 10 weeks after liver transplantation] compared with standard isotonic intravenous glucose solution (low certainty).
1 finding from 1 review